In furtherance to the intimation made by the Company regarding the request received from the Shareholder for issue of duplicate share certificate, Strides Pharma Science has informed that the Company has completed the procedural requirements and dispatched the ‘Letter of Confirmation’ (LoC) to the Shareholder, Satish Gandhi (Folio No. SAL015959) as prescribed under SEBI Circular SEBI/ HO/ MIRSD/ MIRSD_RTAMB/ P/ CIR/ 2022/8 of January 25, 2022.
The above information is a part of company’s filings submitted to BSE.
